Influence of Salbutamol on Emotional and Cognitive Functions in Healthy Subjects
Launched by PROF. DOMINIQUE DE QUERVAIN, MD · Sep 30, 2013
Trial Information
Current as of June 26, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy, male and female, aged between 18 and 40, BMI be-tween 19 and 27 kg/m2, normotensive (BP between 90/60 mmHg and 140/90 mmHg), native or fluent German-speaking, caucasian (European ancestry), able and willing to give written informed consent and comply with the requirements of the study protocol, willing to donate saliva sample for DNA-analysis -
- Exclusion Criteria:
- • Acute or chronic psychiatric or somatic disorder, tachycardia at rest (\> 100 bpm), known hypersensitivity to salbutamol, pathological ECG, pregnancy, breast-feeding, long-term medication within last 3 months (oral contraceptives are disregarded) smoking (\>3 cigarettes per day), concurrent participation in another study, participation in one of our previous studies using the same memory tests, inability to read and understand the participant's information. -
About Prof. Dominique De Quervain, Md
Professor Dominique de Quervain, MD, is a distinguished clinical researcher and expert in the field of neuroscience, with a focus on understanding the neurobiological underpinnings of memory and emotional processing. His work encompasses a range of innovative clinical trials aimed at exploring novel therapeutic approaches for cognitive and mood disorders. With a commitment to advancing medical knowledge and patient care, Professor de Quervain's research integrates cutting-edge methodologies and interdisciplinary collaboration, positioning him as a leader in the pursuit of effective treatments for complex neuropsychiatric conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Patients applied
Trial Officials
Dominique de Quervain, Prof. MD
Study Director
University of Basel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials